GSK
GSK
GSK
785 hedge funds and large institutions have $9.34B invested in GSK in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 302 increasing their positions, 266 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 302 | Existing positions reduced: 266
3% more funds holding
Funds holding: 761 → 785 (+24)
0.2% more ownership
Funds ownership: 3.41% → 3.6% (+0.2%)
Holders
785
Holding in Top 10
11
Calls
$137M
Puts
$84.4M
Top Buyers
| 1 | +$257M | |
| 2 | +$105M | |
| 3 | +$67.7M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$57.8M |
| 5 |
Renaissance Technologies
New York
|
+$55.5M |
Top Sellers
| 1 | -$65.4M | |
| 2 | -$62.3M | |
| 3 | -$51M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$40.5M |
| 5 |
Two Sigma Investments
New York
|
-$37.9M |